News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,097 Results
Type
Article (2496)
Company Profile (39)
Press Release (36558)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (14161)
Career Advice (78)
Deals (2088)
Drug Delivery (9)
Drug Development (4120)
Employer Resources (10)
FDA (434)
Job Trends (773)
News (20198)
Policy (1053)
Tag
Academia (144)
Allergies (7)
Alliances (3490)
ALS (4)
Alzheimer's disease (51)
Antibody-drug conjugate (ADC) (20)
Approvals (433)
Artificial intelligence (18)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (13)
Biotechnology (29)
Bladder cancer (7)
Brain cancer (6)
Breast cancer (28)
Cancer (220)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (22)
Cell therapy (61)
Cervical cancer (2)
Clinical research (3282)
Collaboration (135)
Company closure (2)
Compensation (73)
COVID-19 (181)
CRISPR (9)
C-suite (51)
Cystic fibrosis (5)
Data (218)
Denatured (5)
Depression (7)
Diabetes (15)
Diagnostics (472)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (18)
Drug pricing (8)
Duchenne muscular dystrophy (22)
Earnings (4397)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6204)
Executive appointments (117)
FDA (524)
Funding (106)
Gene editing (20)
Gene therapy (29)
GLP-1 (61)
Government (152)
Guidances (21)
Healthcare (706)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (25)
Immuno-oncology (4)
Indications (3)
Infectious disease (189)
Inflammatory bowel disease (13)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (15)
Interviews (7)
IPO (1000)
IRA (7)
Job creations (291)
Job search strategy (62)
Kidney cancer (6)
Labor market (9)
Layoffs (45)
Leadership (1)
Legal (213)
Liver cancer (6)
Longevity (1)
Lung cancer (20)
Lymphoma (8)
Management (4)
Manufacturing (28)
MASH (6)
Medical device (310)
Medtech (310)
Mergers & acquisitions (1182)
Metabolic disorders (44)
Multiple sclerosis (15)
Neurodegenerative disease (19)
Neuropsychiatric disorders (5)
Neuroscience (123)
NextGen: Class of 2025 (352)
Non-profit (154)
Now hiring (8)
Obesity (20)
Opinion (15)
Ovarian cancer (15)
Pain (14)
Pancreatic cancer (13)
Parkinson's disease (7)
Partnered (2)
Patents (37)
Patient recruitment (10)
Peanut (1)
People (5749)
Pharmaceutical (5)
Phase I (1410)
Phase II (1636)
Phase III (876)
Pipeline (179)
Policy (14)
Postmarket research (30)
Preclinical (616)
Press Release (2)
Prostate cancer (5)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (37)
Real estate (421)
Recruiting (5)
Regulatory (840)
Reports (7)
Research institute (143)
Resumes & cover letters (9)
RNA editing (5)
Schizophrenia (15)
Series A (30)
Series B (11)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (495)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
Vaccines (39)
Venture capital (11)
Weight loss (13)
Women's health (3)
Worklife (1)
Date
Today (11)
Last 7 days (33)
Last 30 days (200)
Last 365 days (2454)
2025 (1644)
2024 (2611)
2023 (2858)
2022 (3755)
2021 (4052)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1798)
2016 (1625)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (2)
Arizona (16)
Asia (1902)
Australia (302)
California (1209)
Canada (188)
China (54)
Colorado (30)
Connecticut (12)
Delaware (4)
Europe (3912)
Florida (52)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (17)
India (1)
Indiana (39)
Japan (12)
Kansas (12)
Kentucky (1)
Maryland (33)
Massachusetts (427)
Michigan (11)
Minnesota (19)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (97)
New York (61)
North Carolina (107)
Northern California (543)
Ohio (31)
Oklahoma (2)
Oregon (5)
Pennsylvania (78)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (501)
Tennessee (3)
Texas (111)
United States (2422)
Utah (3)
Virginia (7)
Washington D.C. (1)
Washington State (69)
West Virginia (1)
Wisconsin (7)
39,097 Results for "caladrius biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022.
September 15, 2022
·
8 min read
Press Releases
Bright Minds Biosciences to Present at Upcoming Conferences
August 25, 2025
·
1 min read
Press Releases
Cogent Biosciences Announces Participation in the Citi Biopharma Conference
August 27, 2025
·
2 min read
Press Releases
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
August 26, 2025
·
1 min read
Pharm Country
Caladrius Biosciences to Present at the BIO International Convention 2022
Caladrius Biosciences, Inc. announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Caladrius, will present a corporate overview at the BIO International Convention being held in-person at the San Diego Convention Center in San Diego, CA, from June 13-16, 2022.
June 8, 2022
·
1 min read
Press Releases
Jade Biosciences to Participate in Upcoming September 2025 Conferences
August 25, 2025
·
3 min read
Pharm Country
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
Caladrius Biosciences, Inc., announced that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of stockholders held September 13, 2022, its stockholders approved all of the merger-related proposals.
September 14, 2022
·
6 min read
Press Releases
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September 2025
August 26, 2025
·
2 min read
Press Releases
Annexon Biosciences to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
1 of 3,910
Next
